CLINICAL TRIALS PROFILE FOR LOMUSTINE
✉ Email this page to a colleague
All Clinical Trials for lomustine
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | Eastern Cooperative Oncology Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | National Cancer Institute (NCI) | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | NCIC Clinical Trials Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | North Central Cancer Treatment Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | Southwest Oncology Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | Radiation Therapy Oncology Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for lomustine
Condition Name
Clinical Trial Locations for lomustine
Trials by Country
Clinical Trial Progress for lomustine
Clinical Trial Phase
Clinical Trial Sponsors for lomustine
Sponsor Name
